Conmed (FRA:EC8) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EC8 Conmed Corp FRA:EC8
81 GF Score
Price €43.80
GF Value €57.51
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Conmed FFO per Share?

FFO per Share only applies to REITs.

FRA:EC8
81GF Score
Conmed Corp FRA:EC8
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Conmed (FRA:EC8) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of €43.80 is trading 23.8% below its estimated GF Value™ of €57.51. GuruFocus considers Conmed to be Modestly Undervalued.

Key valuation signals for FRA:EC8:

  • FFO per Share:
  • GF Value™: €57.51 vs. price of €43.80 (23.8% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the FRA:EC8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Conmed Business Description

Other Exchanges CNMD:USA
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
81GF Score

Get the complete analysis for FRA:EC8

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€43.80
Price
€57.51
GF Value